A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis Meeting Abstract


Authors: Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; Li, J.; Zervoudakis, A.; Hamilton, A.; Won, E.; Do, R. K. G.; O'Reilly, E. M.
Abstract Title: A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy287.002
Language: English
ACCESSION: WOS:000459277301309
PROVIDER: wos
DOI: 10.1093/annonc/mdy287.002
Notes: Meeting Abstract: 730P -- Appears on page viii248 of the abstract book -- Source: Wos
Altmetric Score
MSK Authors
  1. Geoffrey Yuyat Ku
    91 Ku
  2. Maeve Aine Lowery
    97 Lowery
  3. Kenneth Ho-Ming Yu
    62 Yu
  4. Kinh Gian Do
    115 Do
  5. Eileen O'Reilly
    321 O'Reilly
  6. Simon H Mantha
    33 Mantha
  7. Elizabeth Siryeon Won
    23 Won
  8. Nitya Prabhakar Raj
    27 Raj
  9. Catherine Tjan
    2 Tjan
  10. Jia Li
    3 Li